Literatur
Anderson BB, Oberlin DT, Razmaria AA et al (2016) Extraprostatic extension is extremely rare for contemporary Gleason score 6 prostate cancer. Eur Urol. https://doi.org/10.1016/j.eururo.2016.11.028
Bokhorst LP, Alberts AR, Rannikko A et al (2015) Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers. Eur Urol 68:814–821. https://doi.org/10.1016/j.eururo.2015.06.012
Dieffenbacher S, Nyarangi-Dix J, Giganti F et al (2019) Standardized magnetic resonance imaging reporting using the prostate cancer radiological estimation of change in sequential evaluation criteria and magnetic resonance imaging/transrectal ultrasound fusion with transperineal saturation biopsy to select men. Eur Urol Focus. https://doi.org/10.1016/j.euf.2019.03.001
Giganti F, Kirkham A, Allen C et al (2020) Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations. AJR Am J Roentgenol. https://doi.org/10.2214/ajr.20.23985
Giganti F, Moore CM, Punwani S et al (2018) The natural history of prostate cancer on MRI: lessons from an active surveillance cohort. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-018-0058-5
Giganti F, Stabile A, Stavrinides V et al (2020) Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort. Eur Radiol. https://doi.org/10.1007/s00330-020-07256-z
Hettiarachchi D, Geraghty R, Rice P et al (2021) Can the use of serial multiparametric magnetic resonance imaging during active surveillance of prostate cancer avoid the need for prostate biopsies?—A systematic diagnostic test accuracy review. Eur Urol Oncol 4:426–436. https://doi.org/10.1016/j.euo.2020.09.002
Leitlinienprogramm Onkologie der AWMF (2021) S3-Leitlinie Prostatakarzinom. Version 6
Moldovan PC, Van den Broeck T, Sylvester R et al (2017) What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy ? A systematic review and meta-analysis from the European Association of Urology prostate cancer guidelines panel. Eur Urol 72:250–266. https://doi.org/10.1016/j.eururo.2017.02.026
Moore CM, Giganti F, Albertsen P et al (2017) Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology task force. Eur Urol 71:648–655
Moschini M, Carroll PR, Eggener SE et al (2017) Low-risk prostate cancer: identification, management, and outcomes. Eur Urol 72:238–249. https://doi.org/10.1016/j.eururo.2017.03.009
Rajwa P, Pradere B, Quhal F et al (2021) Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis. Eur Urol. https://doi.org/10.1016/j.eururo.2021.05.001
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.E. Handke, M. Graefen, T. Ullrich, A. Wibmer, B.A. Hadaschik, F. Giganti, L. Schimmöller und J.P. Radtke geben an, dass kein Interessenkonflikt besteht.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Handke, A.E., Graefen, M., Ullrich, T. et al. Kann die Progression eines Prostatakarzinoms während Active Surveillance durch serielle Magnetresonanztomographie verlässlich diagnostiziert werden?. Urologe 60, 1594–1597 (2021). https://doi.org/10.1007/s00120-021-01676-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-021-01676-5